zzlangerhans’ Activity

Thu Dec 18

Caps Pick

zzlangerhans made a pick in CAPS. 10:38 AM

AVEO Pharmaceuticals, Inc. (AVEO) will Underperform the S&P 500

Caps Pick

zzlangerhans made a pick in CAPS. 8:29 AM

SOPHIRIS BIO INC COM NPV (POST REV SPLIT) (SPHS) will Outperform the S&P 500

Sat Dec 13

Blog Comment

zzlangerhans commented on EnigmaDude's blog post. 8:19 AM

Anyone else having trouble adding/closing picks?

I'm just amazed that the site is still functional at all.

CAPS Underperform Pitch

zzlangerhans wrote about ARCA Biopharma, Inc. (ABIO) . 1:34 AM

ABIO Underperform

There's not much point rehashing the dissection of Arca I've dumped on this website countless times, with the last being just a month ago. If you really want to check the most recent version, it's here [more]

Thu Dec 11

Caps Pick

zzlangerhans made a pick in CAPS. 9:46 AM

ARCA Biopharma, Inc. (ABIO) will Underperform the S&P 500

Sun Dec 7

CAPS Outperform Pitch

zzlangerhans wrote about Sarepta Therapeutics (SRPT) . 11:06 PM

SRPT Outperform

There's no denying that Sarepta is a cult stock only rivaled by Mannkind. Similarly to Mannkind, Sarepta always seems to overshoot the rational price range in either direction depending on prevailing sentiment, and right now the wind is blowing [more]

Sat Dec 6

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for NBS. 5:28 PM

The Monday after OpEx, NeoStem issued a damage control PR: http://www.neostem.com/media/press-releases/news-item/neostem-provides-further-information-regarding-phase-2-preserve/ NeoStem starts out by saying "we are extremely disappointed, in the [more]

CAPS Outperform Pitch

zzlangerhans wrote about Neostem, Inc. (NBS) . 4:17 PM

NBS Outperform

I'm sure many people interested in stocks wonder why I would obsess over a shady microcap stem cell biotech like NeoStem. In turn, I wonder why so much stock commentary is devoted to behemoths like Apple, Tesla, and Facebook. Don't retail traders [more]

Fri Dec 5

CAPS Outperform Pitch

zzlangerhans wrote about Prothena Corporation (PRTA) . 8:16 PM

PRTA Outperform

Prothena doesn't seem to have impressed the street much with their recent announcement of positive interim data from the phase I/II trial of NEOD001 anti-amyloid mAb for amyloid light chain (AL) amyloidosis. The company reported a 50% cardiac [more]

Wed Dec 3

CAPS Outperform Pitch Reply

zzlangerhans commented on bburr4307's pitch for ATHX. 7:41 PM

So far there are 1000's of bagholders, so you were almost right.

Caps Pick

zzlangerhans made a pick in CAPS. 12:19 PM

Prothena Corporation (PRTA) will Outperform the S&P 500

Tue Dec 2

CAPS Underperform Pitch

zzlangerhans wrote about CELLCEUTIX CORP (CTIX) . 11:26 PM

CTIX Underperform

It's not easy to keep up with all the scams and cons in biopharma these days but every once in a while my kids actually go to sleep and don't wake up an hour later, and I have to make the most of it. Cellceutix is a fun one for several reasons, not [more]

Caps Pick

zzlangerhans made a pick in CAPS. 3:22 PM

CELLCEUTIX CORP (CTIX) will Underperform the S&P 500

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for NBS. 3:00 PM

Yes, I still feel they are a scam. There will be a new pitch by the end of the week.

Caps Pick

zzlangerhans made a pick in CAPS. 2:59 PM

Neostem, Inc. (NBS) will Outperform the S&P 500

Caps Pick

zzlangerhans made a pick in CAPS. 10:24 AM

Sarepta Therapeutics (SRPT) will Outperform the S&P 500

Sun Nov 30

CAPS Outperform Pitch

zzlangerhans wrote about Theravance Biopharma, Inc. - Ordinary Shares (TBPH) . 2:04 AM

TBPH Outperform

When Theravance Biopharma was spun off from Theravance Inc. in June, I decided to liquidate my dividend of 171 shares at about 31. It turned out to be a good move, since the share price rose a little higher but has subsequently declined steadily and [more]

Caps Pick

zzlangerhans made a pick in CAPS. 2:04 AM

Theravance Biopharma, Inc. - Ordinary Shares (TBPH) will Outperform the S&P 500

Sun Nov 23

CAPS Underperform Pitch

zzlangerhans wrote about Novavax, Inc. (NVAX) . 10:40 AM

NVAX Underperform

I don't mind admitting that I don't really understand Novavax. All I know is that I've been following this company off and on for more than seven years and I've never even heard them discuss running a phase III trial. It just seems to be a [more]

Caps Pick

zzlangerhans made a pick in CAPS. 9:49 AM

Novavax, Inc. (NVAX) will Underperform the S&P 500
Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.85
Player Rank 113 out of 75070
Score 7743.45
Score Change Today -71.05
Accuracy 82.16%
Active Picks 153
Total Picks 1967
Best Pick SCTPF (+1283.64)
Worst Pick PCYC (-2886.09)
Average Score per Pick 3.94
Charms Earned 15
Highest Rated Favorite usubanas
Go to zzlangerhans’ CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show zzlangerhans’ 10 Latest Posts